Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsBusinessIPO

Emcure Pharmaceuticals files DRHP for proposed Rs 4,500-Rs 5000 crore IPO

Emcure Pharma IPO comprises a fresh issue of equity shares aggregating up to Rs. 1,100 crores and an offer for sale of up to 18,168,356 equity shares. Bain Capital

August 19, 2021 / 03:26 PM IST
Representative image

Representative image

Emcure Pharmaceuticals, on August 19 filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for its proposed initial public offer (IPO).

Market sources told Moneycontrol that the IPO size would be in the range of of Rs 4500 crore - Rs 5000 crore.

On October 22, 2019, Moneycontrol was the first to report that Emcure Pharma would pursue an internal rejig and then revive its listing plans

The initial public offering comprises a fresh issue of equity shares aggregating up to Rs. 1,100 crore and an offer for sale of up to 18,168,356 equity shares that include promoters - Satish Mehta selling up to 2,030,000 equity shares and Sunil Mehta aggregating up to 2,50,000 equity shares. Other selling shareholders include private equity investor Bain Capital, as well as certain individual selling shareholders.